- Home
- EWTX vs MHO Comparison
EWTX vs MHO Comparison
Compare EWTX & MHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EWTX | MHO |
|---|---|---|
| Founded | 2017 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.4B |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | EWTX | MHO |
|---|---|---|
| Price | $39.77 | $146.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $39.00 | ★ $160.00 |
| AVG Volume (30 Days) | ★ 1.6M | 273.1K |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.55 |
| Revenue | N/A | ★ $4,417,781,000.00 |
| Revenue This Year | N/A | $0.66 |
| Revenue Next Year | N/A | $6.97 |
| P/E Ratio | ★ N/A | $57.51 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.31 | $116.78 |
| 52 Week High | $48.40 | $163.66 |
Technical Indicators
Market Signals| Indicator | EWTX | MHO |
|---|---|---|
| Relative Strength Index (RSI) | 50.12 | 47.27 |
| Support Level | $38.36 | $144.17 |
| Resistance Level | $40.36 | $152.14 |
| Average True Range (ATR) | 2.69 | 4.07 |
| MACD | -0.66 | -1.29 |
| Stochastic Oscillator | 21.97 | 11.04 |
Price Performance
Historical ComparisonAbout EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.
About MHO M/I Homes Inc.
M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprises a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.